ClinicalTrials.gov
public full text
Public Domain
A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors
This is a multicenter, open-label, multiple-dose, FIH Phase 1a/1b study. Phase 1a adopts an accelerated titration design and a BOIN design to identify the MTD or MAD of DB-1317; Phase 1b includes one randomized dose expansion cohort and two single-arm dose expansion cohorts to further evaluate the safety, tolerability and preliminary efficacy of DB-1317 in selected solid tumors and to identify optimal RP2D.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of DB-1310 in Advanced/Metastatic Solid Tumors#918291
- A Study of BA1202 in Patients With Advanced Solid Tumors#1371194
- A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors#804465
- ARQ 197 in Subjects With Metastatic Solid Tumors#967030
- A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors#1279973
Record · ID 1231118
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive